| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Boston Scientific Corp (BSX) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. BSX is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 168.0K | $7.45M | - | |
| CFO | 35.8K | $1.59M | - | |
| VP | 35.4K | $1.57M | - | |
| VP | 30.6K | $1.35M | - | |
| Dir | 24.1K | $1.07M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2023 | Monson Jonathan | SVP, Global Controller And CAO | Sale+OE | 5,000 | $46.66 | $233,315.00 | -12.5% | +7.8% | +41.4% | |
| Feb 22, 2023 | Mirviss Jeffrey B.45 | EVP&Pres, Periph Intervent | Sale+OE | 5,653 | $46.19 | $261,112.16 | -3.0% | +10.5% | +43.2% | |
| Feb 17, 2023 | Mirviss Jeffrey B.45 | EVP&Pres, Periph Intervent | Sale+OE | 3,470 | $46.53 | $161,454.46 | -1.9% | +14.8% | +41.4% | |
| Feb 15, 2023 | Brennan Daniel J.47 | EVP And CFO | Sale+OE | 7,572 | $47.14 | $356,927.42 | -2.7% | +13.7% | +39.8% | |
| Feb 3, 2023 | Butcher Arthur C46 | EVP&Grp Pres, Medsurg &Apac | Sale+OE | 27,000 | $48.74 | $1,316,036.70 | -53.6% | +7.1% | +32.7% | |
| Jan 4, 2023 | Mirviss Jeffrey B.45 | EVP&Pres, Periph Intervent | Sell | 6,751 | $46.38 | $313,122.86 | -7.1% | +7.7% | +25.1% | |
| Dec 15, 2022 | Carruthers Wendy | EVP, Human Resources | Sell | 7,500 | $46.62 | $349,668.00 | -7.9% | +3.6% | +20.5% | |
| Dec 13, 2022 | Fitzgerald Joseph Michael51 | EVP &Group Pres, Cardiology | Sale+OE | 79,264 | $47.78 | $3,787,233.92 | -26.8% | +0.8% | +19.7% | |
| Dec 12, 2022 | Mirviss Jeffrey B.45 | EVP&Pres, Periph Intervent | Sell | 11,080 | $46.75 | $517,990.00 | -11.1% | +1.0% | +18.7% | |
| Dec 9, 2022 | Mirviss Jeffrey B.45 | EVP&Pres, Periph Intervent | Sale+OE | 41,032 | $46.15 | $1,893,503.70 | -29.2% | +1.8% | +18.9% |